Breast cancer care: Does the NHS discriminate against women living in deprived areas? - European Journal of Cancerdoi:10.1016/S0959-8049(98)80306-7U. MacleodS. RossC. J. TwelvesC. GillisG. C. M. WattEuropean Journal of Cancer
阅读量: 16 作者: U. Macleod,S. Ross,C. J. Twelves,C. Gillis,G. C. M. Watt 展开 摘要: Breast cancer care: Does the NHS discriminate against women living in deprived areas? - European Journal of Cancer 展开 DOI: 10.1016/S0959-8049(98)80306-7 被引量: 13 年份: 1998 收藏...
The latter may have patients with better access to health care or greater interest in their health, and the increased surveillance provided in these centers could also affect the prognosis. There are also differences between the participating countries in breast cancer screening and management. For ...
on the causal pathway, but designing such trials is challenging because of the large sample size required and the expense of collecting long-term follow-up data. alcohol it is estimated that breast cancer risk is increased by 7% to 10% for each one-unit increase in intake of alcohol per ...
North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK D. Gareth Evans David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncol...
NHS临床指南CanadianTaskForceonPreventiveHealthCare BreastCancerScreeningRecommendations2011 WhoistheCTFPHC?•TheCanadianTaskForceonPreventiveHealthCare(CTFPHC)–Comprisedof14primarycareexperts–Establishedtodevelopclinicalpracticeguidelinesthatsupport primarycareprovidersindeliveringpreventivehealthcare–Identifyevidencegaps...
Introduction: Full Field Digital mammography (FFDM) gradually replaced film screen mammography (FSM) in the English NHS breast cancer screening programme (NHSBSP) between 2008 and 2015. We report, for the first time, the impact of digital mammography in a large organised national screening programme...
More than 100 internationally recognised specialist breast cancer scientists, clinicians and healthcare professionals collaborated to address nine thematic areas: genetics, epigenetics and epidemiology; molecular pathology and cell biology; hormonal influences and endocrine therapy; imaging, detection and screenin...
Cambridge Breast Cancer Research Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 2QQ, UK Jean E. Abraham & Carlos Caldas Contributions KDH, TM, SLC, S-FC, and JCP performed the ...
“This is a dark day for people affected by incurable secondary breast cancer. NHS England, Nice, Daiichi Sankyo and AstraZeneca have failed people living with the disease,” said Baroness Delyth Morgan, chief executive of charity Breast Cancer Now. ...